Latest News and Press Releases
Want to stay updated on the latest news?
-
Cohen Milstein Encourages Zenas BioPharma Investors Who Lost Money Following IPO Stock Collapse to Call Firm to Potentially Join or Lead Class Action.
-
Investors who purchased stock in Zenas BioPharma, Inc. (NASDAQ: ZBIO) September 2024 IPO and lost money should call Cohen Milstein to join a class action.
-
First Federal Savings Bank and ICBA Provide Tips to Safeguard Sensitive Information During Data Privacy Week